相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update
Kirk E. Evoy et al.
DRUGS (2021)
Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample
Kirk E. Evoy et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)
Trends in Gabapentin Prescribing in a Commercially Insured US Adult Population, 2009-2016
Nathan J. Pauly et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2020)
Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016
Lili Zhou et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland
Nicola Torrance et al.
BRITISH JOURNAL OF ANAESTHESIA (2020)
The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015
Tanner Nassau et al.
PUBLIC HEALTH REPORTS (2020)
Gabapentin-induced drug-seeking-like behavior: a potential role for the dopaminergic system
Yusuf S. Althobaiti et al.
SCIENTIFIC REPORTS (2020)
What about Pharming? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs
Stefania Chiappini et al.
BRAIN SCIENCES (2020)
Hospital admissions among people who inject opioids following syringe services program implementation
K. J. Bornstein et al.
HARM REDUCTION JOURNAL (2020)
Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice
Mahindra Chincholkar
BRITISH JOURNAL OF PAIN (2020)
Preliminary Evidence of Pregabalin Misuse among Prescription and/or Illicit Opioid (Mis)users
Mance E. Buttram et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2020)
Use of promethazine, gabapentin and clonidine in combination with opioids or opioid agonist therapies among individuals attending a syringe service program
Dinah Applewhite et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2020)
The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017
Steven P. Kurtz et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
A Clinical Overview of Off-label Use of Gabapentinoid Drugs
Christopher W. Goodman et al.
JAMA INTERNAL MEDICINE (2019)
Misuse and Mortality Related to Gabapentin and Pregabalin are Being Under-Estimated: A Two-Year Post-Mortem Population Study
Limon Khatun Nahar et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2019)
Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden
Yasmina Molero et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Management of overdoses of loperamide, gabapentin, and modafinil: a literature review
Justin P. Reinert et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
An ethnographic decision model of the initiation of gabapentin misuse among prescription and/or illicit opioid (mis)user
Mance E. Buttram et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism
Yusuf S. Althobaiti et al.
SCIENTIFIC REPORTS (2019)
Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records
John Macleod et al.
PLOS MEDICINE (2019)
Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications A Systematic Review
Carole A. Federico et al.
JAMA INTERNAL MEDICINE (2019)
Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics
Kirk E. Evoy et al.
SUBSTANCE ABUSE-RESEARCH AND TREATMENT (2019)
Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS)
Kirk E. Evoy et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2019)
Establishment of a comprehensive drug overdose fatality surveillance system in Kentucky to inform drug overdose prevention policies, interventions and best practices
Sarah L. Hargrove et al.
INJURY PREVENTION (2018)
Decline in opioid prescribing after federal rescheduling of hydrocodone products
Mukaila A. Raji et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences
Amneh Al-Husseini et al.
INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION (2018)
Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak
Monita R. Patel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts
Joshua D. Wallach et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The FDA and the Next Wave of Drug Abuse - Proactive Pharmacovigilance
Douglas C. Throckmorton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
ON THE ADDICTIVE POWER OF GABAPENTINOIDS: A MINI-REVIEW
Udo Bonnet et al.
PSYCHIATRIA DANUBINA (2018)
Gabapentinoid Use in the United States 2002 Through 2015
Michael E. Johansen
JAMA INTERNAL MEDICINE (2018)
Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study
Tara Gomes et al.
ANNALS OF INTERNAL MEDICINE (2018)
Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017
Francois Montastruc et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
Alyssa M. Peckham et al.
SUBSTANCE ABUSE-RESEARCH AND TREATMENT (2018)
A Qualitative Analysis of Gabapentin Misuse and Diversion Among People Who Use Drugs in Appalachian Kentucky
Rachel Vickers Smith et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2018)
Intentional Drug Overdose Involving Pregabalin and Gabapentin: Findings from the National Self-Harm Registry Ireland, 2007-2015
Caroline Daly et al.
CLINICAL DRUG INVESTIGATION (2018)
All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population
Alyssa M. Peckham et al.
DRUG SAFETY (2018)
Unilateral hemorrhagic macular infarction associated with marijuana, alcohol and antiepileptic drug intake
Serdar Aktas et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2017)
Determining the Toxicological Significance of Pregabalin in Fatalities
Simon P. Elliott et al.
JOURNAL OF FORENSIC SCIENCES (2017)
How addictive are gabapentin and pregabalin? A systematic review
U. Bonnet et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
An Atypical Withdrawal Syndrome in Neonates Prenatally Exposed to Gabapentin and Opioids
Sean Loudin et al.
JOURNAL OF PEDIATRICS (2017)
Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings
Mance E. Buttram et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Loperamide Trends in Abuse and Misuse Over 13 Years: 2002-2015
Daniel R. Lasoff et al.
PHARMACOTHERAPY (2017)
Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study
Krista F. Huybrechts et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study
Tara Gomes et al.
PLOS MEDICINE (2017)
Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study
Krista F. Huybrechts et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Opioid Prescription Trends Among Patients With Cancer Referred to Outpatient Palliative Care Over a 6-Year Period
Ali Haider et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Pregabalin Use Among Users of Illicit Drugs: A Cross-Sectional Survey in Southern Germany
Brendan J. Snellgrove et al.
CNS DRUGS (2017)
Risk to heroin users of polydrug use of pregabalin or gabapentin
Abigail Lyndon et al.
ADDICTION (2017)
Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population
Alyssa M. Peckham et al.
CLINICAL DRUG INVESTIGATION (2017)
Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study
Tove Abrahamsson et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Abuse and Misuse of Pregabalin and Gabapentin
Kirk E. Evoy et al.
DRUGS (2017)
Gabapentin: Abuse, Dependence, and Withdrawal
Tracey L. Mersfelder et al.
ANNALS OF PHARMACOTHERAPY (2016)
Gabapentin misuse, abuse and diversion: a systematic review
Rachel V. Smith et al.
ADDICTION (2016)
A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database
Stefania Chiappini et al.
CNS DRUGS (2016)
An acute gabapentin fatality: a case report with postmortem concentrations
F. Lee Cantrell et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2015)
Mandatory Use of Prescription Drug Monitoring Programs
Rebecca L. Haffajee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Gabapentin Dependence in a Patient With Opioid Dependence Syndrome
Rasaily Satish et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2015)
Neonatal Gabapentin Withdrawal Syndrome
Melisa Carrasco et al.
PEDIATRIC NEUROLOGY (2015)
Novel psychoactive substances of interest for psychiatry
Fabrizio Schifano et al.
WORLD PSYCHIATRY (2015)
Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK
Vikas Kapil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Clinical Outcomes in Newer Anticonvulsant Overdose: A Poison Center Observational Study
Brandon Wills et al.
JOURNAL OF MEDICAL TOXICOLOGY (2014)
Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers
James P. Zacny et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials
Gaetano Zaccara et al.
EPILEPSIA (2011)
Suicide by Gabapentin Overdose
Owen Middleton
JOURNAL OF FORENSIC SCIENCES (2011)
Is There a Recreational Misuse Potential for Pregabalin? Analysis of Anecdotal Online Reports in Comparison with Related Gabapentin and Clonazepam Data
Fabrizio Schifano et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2011)
Withdrawal symptoms after gabapentin discontinuation
Thaddaus R. Hellwig et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2010)
Pregabalin Abuse, Dependence, and Withdrawal: A Case Report
Martin Grosshans et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
Howard N. Bockbrader et al.
CLINICAL PHARMACOKINETICS (2010)
Pregabalin: Its pharmacology and use in pain management
Noor M. Gajraj
ANESTHESIA AND ANALGESIA (2007)
Conversions between monotherapies in epilepsy: Expert consensus
Erik K. St. Louis et al.
EPILEPSY & BEHAVIOR (2007)
Cardiac conduction disturbances after an overdose of nefazodone and gabapentin
Joseph J. Rasimas et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2006)
α2δ and the mechanism of action of gabapentin in the treatment of pain
Y. P. Maneuf et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2006)
Gabapentin: pharmacology and its use in pain management
MA Rose et al.
ANAESTHESIA (2002)
Gabapentin withdrawal presenting as status epilepticus
F Barrueto et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2002)
分享论文
